ClinicalTrialsFinder

The state institution N. N. Alexandrov National Cancer Centre of Belarus

Minsk, Minsk City, Belarus

1 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II

Gastric Cancer With Peritoneal Dissemination
Research Institute for Physical Chemical Problems of the Belarusian State University120 enrolled1 locationNCT06232434